<DOC>
	<DOCNO>NCT02630459</DOCNO>
	<brief_summary>Randomized , double-blind , placebo-controlled , parallel-group , multicenter study follow open-label treatment phase . To evaluate effect AMG 334 compare placebo change baseline monthly migraine day .</brief_summary>
	<brief_title>A Safety Efficacy Study Evaluate AMG 334 Migraine Prevention</brief_title>
	<detailed_description>This Phase 2 , randomize , double-blind , placebo-controlled study subject episodic migraine . The study design evaluate treatment AMG 334 month 6 month compare placebo effective reduce mean monthly migraine day . Additionally , study continue evaluate efficacy safety AMG 334 open label treatment phase subject continue receive active treatment monthly .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Initial Screening Baseline Phase History migraine ( without aura ) ≥ 12 month prior screen accord IHS Classification ICHD3 ( Headache Classification Committee International Headache Society , 2013 ) , Migraine frequency : ≥ 4 &lt; 15 migraine day per month average across 3 month prior screen , Headache frequency : &lt; 15 headache day per month average across 3 month prior screen baseline , Demonstrated least 80 % compliance eDiary . Older 50 year age migraine onset , History cluster headache hemiplegic migraine headache , Unable differentiate migraine headache , Used prohibit medication , device , procedure prior start baseline phase baseline phase , More 1 migraine prophylactic medication within 2 month , Botulinum toxin head neck region within 4 month , Ergotaminederivatives , steroid , triptans use migraine prophylaxis within 2 month . Devices procedure use migraine prophylaxis , No therapeutic response &gt; 2 medication category prophylactic treatment migraine adequate therapeutic trial .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Migraine Prevention</keyword>
	<keyword>Headache</keyword>
	<keyword>Prophylaxis</keyword>
</DOC>